Tao Liu

28PUBLICATIONS
52CO-AUTHORS
Separation technologiesGene and molecular therapyReaction engineering (excl. nuclear reactions)Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Oct 29, 2026
Protease-Responsive Condensation of Engineered Proteins Drives Tumor-Targeted T-Cell Activation.

|Sep 29, 2026
Controllable gene delivery via masked adeno-associated viral vectors.

|Aug 31, 2026
Engineering inflammation-responsive proteins through nitric oxide-caged amino acids.

|Aug 29, 2026
A Tumor-Microenvironment-Responsive Chemically Masked IL‑2 Prodrug Potentiates PD‑1 Checkpoint Blockade and Elicits Robust Antitumor Efficacy.

|Jun 04, 2026
Chemically Masked aPD-L1-Sialidase Conjugate for Tumor-Specific Desialylation and Immunotherapy.

|Apr 29, 2026
Tumor Microenvironment-Responsive Antibody Fragment-Cleavable PEGylated Drug Conjugates (AFCDC) for Improved Tumor Penetration and Antitumor Efficacy.

Pageof 5

Frequent Collaborators

6 joint publications

Yong Wang

3 joint publications

Xiaoding Lou

3 joint publications

Haoyu Wang

2 joint publications

Xinyu Ling